Career Enhancement Program

职业提升计划

• 批准号: 10415973
• 负责人: Scott Kopetz
• 金额: $ 15.27万
• 依托单位: UNIVERSITY OF TX MD ANDERSON CAN CTR
• 依托单位国家: 美国
• 财政年份: 2019
• 资助国家: 美国
• 起止时间: 2019-08-20 至 2024-05-31
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/10415973
• 关键词: Academic Training; American Association of Cancer Research; American Society of Clinical Oncology; Area; Award; Basic Science; Budgets; Caliber; Cancer Biology; Cancer Center; Clinical; Clinical Trials; Clinical trial protocol document; Colorectal Cancer; Country; Development; Development Plans; Diagnosis; Disease; Early Diagnosis; Ensure; Feedback; Fellowship; Financial Support; Funding; Goals; Grant; Individual; Institutes; Institution; International; Journals; Knowledge; Laboratories; Laboratory Research; Lead; Leadership; Malignant neoplasm of gastrointestinal tract; Malignant neoplasm of pancreas; Manuscripts; Mentors; Mentorship; Minority Women; Morbidity - disease rate; Nature; Oncology; Pathology; Patients; Peer Review; Physicians; Prevention; Process; Publications; Publishing; Quality of life; Research; Research Personnel; Research Project Grants; Scientist; Site; Survivors; Training; Training Programs; Translating; Translational Research; Underrepresented Populations; Universities; University of Texas M D Anderson Cancer Center; Woman; Writing; anticancer research; base; cancer diagnosis; career; career development; clinical care; design; flexibility; gastrointestinal; improved; innovation; interest; meetings; member; mortality; next generation; programs; recruit; symposium; training opportunity; translational approach; translational potential; translational research program; translational scientist

CAREER ENHANCEMENT PROGRAM: Summary/Abstract The goal of the Career Enhancement Program (CEP) is to develop highly trained, exceptional young investigators dedicated to translational research in the early detection, prevention, and treatment of pancreatic cancer (PDAC) and colorectal cancer (CRC). Ideally, these investigators will ultimately help to reduce the morbidity and mortality from these diseases. The CEP will extend be available across both participating institutions –MD Anderson and Johns Hopkins University, broadening the scope of expertise and mentorship opportunities available to early career investigators. Underscoring the shared nature of our program, the CEP will be led by Drs. Elizabeth Jaffee at Johns Hopkins and Dr, Scott Kopetz at MD Anderson, respectively. The CEP will A) recruit and train physicians and basic scientists to enable them to become highly skilled translational investigators in the field of PDAC or CRC B) provide specific knowledge of research in PDAC or CRC that will enhance the ability of awardees to conduct innovative translational science that will directly impact on the understanding and treatment of these diseases; and 3) re-direct individuals who have already shown considerable scientific promise into PDAC or CRC research. To achieve this goal, the SPORE CEP will provide up to five awards of $50,000 each annually for one year, with a competitive option for renewal for an additional year, funded from the SPORE and matching funds from MD Anderson and Johns Hopkins. We will aggressively recruit the most promising young investigators and institute an individualized development plan with clinical and laboratory mentors and a mentoring committee that will provide coaching in grant and manuscript writing, leadership training, networking with PDAC and CRC scholars (including key opinion leaders in concurrently funded SPORE programs around the country), and completing and publishing translational PDAC or CRC related manuscripts in high impact peer reviewed journals. The GI SPORE will utilize multiple programs inside and outside of the Institute to identify outstanding young investigators with an emphasis placed on recruiting qualified women and members of traditionally underrepresented groups. The CEP will also encourage and support awardee presentations at national or international meetings. The ultimate deliverable of our CEP is to train and cultivate the highest caliber of next generation translational research scientists in GI cancers.

职业提升计划：摘要/摘要 职业提升计划（CEP）的目标是培养训练有素、杰出的年轻人， 致力于胰腺癌的早期检测、预防和治疗的转化研究的研究人员。 癌症（PDAC）和结肠直肠癌（CRC）。理想情况下，这些调查人员最终将有助于减少 发病率和死亡率。CEP将扩展到两个参与 机构-MD安德森和约翰霍普金斯大学，扩大专业知识和指导的范围 为早期职业调查员提供机会。强调我们的计划，CEP的共享性质 将分别由约翰霍普金斯大学的Elizabeth Jaffee博士和MD安德森大学的Scott Kopetz博士领导。的 CEP将A）招募和培训医生和基础科学家，使他们成为高技能的翻译人员。 PDAC或CRC领域的研究者B）提供PDAC或CRC研究的具体知识， 提高获奖者进行创新转化科学的能力，这将直接影响 了解和治疗这些疾病;和3）重新指导那些已经表现出 在PDAC或CRC研究中有相当大的科学前景。为了实现这一目标，SPORE CEP将提供 最多五个奖项，每个奖项每年50，000美元，为期一年，并有竞争力的选择，可以续约一年。 一年，由孢子资助和匹配的资金从MD安德森和约翰霍普金斯。我们将积极 招募最有前途的年轻研究人员，并制定个性化的发展计划， 实验室导师和指导委员会将提供资助和手稿写作方面的指导， 领导力培训，与PDAC和CRC学者建立联系（包括同时在 资助的全国各地的SPORE计划），并完成和出版PDAC或CRC相关的翻译 高影响力同行评审期刊上的手稿。GI孢子将利用内部的多个程序， 在研究所之外，以确定优秀的年轻研究人员，重点是招募合格的 妇女和传统上代表性不足的群体的成员。CEP还将鼓励和支持 获奖者在国家或国际会议上的发言。我们CEP的最终交付成果是培训和 培养下一代消化道癌症转化研究科学家的最高水平。